Skip to main content
SpringerLink
Log in

Gender Differences in Coronary Risk Factors and Risk Interventions

  • Chapter
Atlas of Atherosclerosis

  • 138 Accesses

Abstract

As was noted in the Framingham Heart Study [1,2], women develop any initial manifestations of coronary heart disease (CHD) approximately 10 years later than men and incur myocardial infarction (MI) on average as much as 20 years later. With progres- sive aging of the US population and more women surviving to an older age when CHD becomes clinically manifest, several gender differences have been highlighted. The more adverse outcome has been prominent, with increased case fatality rates and greater morbidity of women after both MI [2–4] and myocardial revascu- larization procedures [5]. Since 1984, more women than men die of cardiovascular disease in the United States. This underscores the need to undertake preventive interventions across the lifespan [4].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. American Heart Association: 2001 Heart and Stroke Statistical Update. Dallas: American Heart Association; 2000.

    Google Scholar 

  2. Kannel WB, Abbott RD: Incidence and prognosis of myocardial infarction in women: the Framingham Study. In Coronary Heart Disease in Women. Edited by Eaker ED, Packard B, Wenger NK, et al. New York: Haymarket Doyma Inc.; 1987:208–214.

    Google Scholar 

  3. Abbott RD, Donahue RP, Kannel WB, et al.: The impact of diabetes on survival following myocardial infarction in men vs women. The Framingham Study. JAMA 1988, 260:3456–3460.

    Article  PubMed  CAS  Google Scholar 

  4. Wenger NK: Clinical characteristics of coronary heart disease in women: emphasis on gender differences. Cardiovasc Res 2002, 53:558–567.

    Article  PubMed  CAS  Google Scholar 

  5. Edwards FH, Carey JS, Grover FL, et al.: Impact of gender on coro- nary bypass operative mortality. Ann Thorac Surg 1998, 66:125–131.

    Article  PubMed  CAS  Google Scholar 

  6. Eaker ED, Chesebro JH, Sacks FM, et al.: Cardiovascular disease in women. Circulation 1993, 88:1999–2009.

    Article  PubMed  CAS  Google Scholar 

  7. Centers for Disease Control and Prevention: Missed opportunities in preventive counseling for cardiovascular disease: United States 1995. MMWR Morb Mortal Wkly Rep 1998, 47:91–95.

    Google Scholar 

  8. Mosca L, Grundy SM, Judelson D, et al.: Guide to preventive cardi- ology for women. Circulation 1999, 99:2480–2484.

    Article  PubMed  CAS  Google Scholar 

  9. Centers for Disease Control: Coronary heart disease incidence by sex—United States, 1971–1987. MMWR Morb Mortal Wkly Rep 992, 41:526–529.

    Google Scholar 

  10. Williams EL, Winkleby MA, Fortmann SP: Changes in coronary heart disease risk factors in the 1980s: evidence of a male-female crossover effect with age. Am J Epidemiol 1993, 137:1056–1067.

    PubMed  CAS  Google Scholar 

  11. Barrett-Connor EL, Cohn BA, Wingard DL, et al.: Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernardo Study. JAMA 1991, 265:627–631.

    Article  PubMed  CAS  Google Scholar 

  12. Kannel WB, McGee DL: Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham Study. Diabetes Care 1979, 2:120–126.

    Article  PubMed  CAS  Google Scholar 

  13. Krolewski AS, Warram JH, Valsania P, et al.: Evolving natural history of coronary artery disease in diabetes mellitus. Am J Med 1991, 90(suppl 2A):56s-61s.

    Article  PubMed  CAS  Google Scholar 

  14. Manson JE, Colditz GA, Stampfer MJ, et al.: A prospective study on maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women. Arch Intern Med 1991, 151:1141–1147.

    Article  PubMed  CAS  Google Scholar 

  15. Liao Y, Cooper RS, Ghali JK, et al.: Sex differences in the impact of coexistent diabetes on survival in patients with coronary heart disease. Diabetes Care 1993, 16:708–713.

    Article  PubMed  CAS  Google Scholar 

  16. Donanue RP, Goldberg RJ, Chen Z, et al.: The influence of sex and diabetes mellitus on survival following acute myocardial infarction: a community-wide perspective. J Clin Epidemiol 1993, 46:245–252.

    Article  Google Scholar 

  17. Goldschmid MG, Barrett-Connor E, Edelstein SL, et al.: Dyslipidemia and ischemic heart disease mortality among men and women with diabetes. Circulation 1994, 89:991–997.

    Article  PubMed  CAS  Google Scholar 

  18. Modan M, Or J, Karasik A, et al.: Hyperinsulinemia, sex, and risk of atherosclerotic cardiovascular disease. Circulation 1991, 84:1165–1175.

    Article  PubMed  CAS  Google Scholar 

  19. Hansen EF, Andersen LT, Von Eyben FE: Cigarette smoking and age at first acute myocardial infarction, and influence of gender and extent of smoking. Am J Cardiol 1993, 71:1439–1442.

    Article  PubMed  CAS  Google Scholar 

  20. Willett WC, Green A, Stampfer MJ, et al.: Relative and absolute excess risks of coronary heart disease among women who smoke cigarettes.N Engl J Med 1987, 317:1303–1309.

    Article  PubMed  CAS  Google Scholar 

  21. Perkins J, Dick TBS: Smoking and myocardial infarction: secondary prevention. Postgrad Med J 1985,61:295–300.

    Article  PubMed  CAS  Google Scholar 

  22. Hermanson B, Omenn GS, Kronmal RA, et al., and Participants in the Coronary Artery Surgery Study: Beneficial six-year outcome of smoking cessation in older men and women with coronary artery disease. Results from the CASS Registry. N Engl J Med 1988, 319:1365–1369.

    Article  PubMed  CAS  Google Scholar 

  23. Coambs RB, Li S, Kozlowski LT: Age interacts with heaviness of smoking in predicting success in cessation of smoking. Am J Epidemiol 1992, 135:240–246.

    PubMed  CAS  Google Scholar 

  24. Rosenberg L, Kaufman DW, Helmrich SP, et al.: Myocardial infarction and cigarette smoking in women younger than 50 years of age. JAMA 1985,253:2965–2969.

    Article  PubMed  CAS  Google Scholar 

  25. Johnson CL, Rifkind BM, Sempos CT, et al.: Declining serum total cholesterol levels among US adults. The National Health and Nutrition Examination Surveys. JAMA 1993, 269:3002–3008.

    Article  PubMed  CAS  Google Scholar 

  26. Campos H, McNamara JR, Wilson PWF, et al.: Differences in low density lipoprotein subtractions and apolipoproteins in premenopausal and postmenopausal women. J Clin Endocrinol Metab 1988, 67:30–35.

    Article  PubMed  CAS  Google Scholar 

  27. Razay G, Heaton KW, Bolton CH: Coronary heart disease risk factors in relation to the menopause. Q J Med 1992, 85:889–896.

    CAS  Google Scholar 

  28. Kuller LH, Simkin-Silverman LR, Wing RR, et al.: Women’s healthy lifestyle project: a randomized clinical trial: results at 54 months. Circulation 2001, 103:32–37.

    Article  PubMed  CAS  Google Scholar 

  29. Kannel WB: Nutrition and the occurrence and prevention of cardiovas- cular disease in the elderly. Nutr Rev 1988, 46:68–78.

    Article  PubMed  CAS  Google Scholar 

  30. Manolio TA, Pearson TA, Wenger NK, et al.: Cholesterol and heart disease in older persons and women. Review of an NHLBI work- shop. Ann Epidemiol 1992, 2:161–176.

    Article  PubMed  CAS  Google Scholar 

  31. Castelli WP: The triglycerides issue: a view from Framingham. Am Heart J 1986,112:432–437.

    Article  PubMed  CAS  Google Scholar 

  32. Bush TL, Criqui MH, Cowan LD, et al.: Cardiovascular disease mortality in women: results from the Lipid Research Clinics Follow-up Study. In Coronary Heart Disease in Women. Edited by Eaker ED, Packard B, Wenger NK, et al. New York: Haymarket Doyma Inc.; 1987:106–111.

    Google Scholar 

  33. Criqui MH, Heiss G, Cohn R, et al.: Plasma triglyceride level and mortality from coronary heart disease. N Engl J Med 1993, 328:1220–1225.

    Article  PubMed  CAS  Google Scholar 

  34. Assmann G, Schulte H: The importance of triglycerides: results from the Prospective Cardiovascular Munster (PROCAM) Study. Eur J Epidemiol 1992, 8(suppl 1):99–103.

    Article  PubMed  Google Scholar 

  35. Gordon DJ, Probstfield JL, Garrison RJ, et al: High-density lipopro- tein cholesterol and cardiovascular disease: four prospective American studies. Circulation 1989, 79:8–15.

    Article  PubMed  CAS  Google Scholar 

  36. Wong ND, Wilson PWF, Kannel WB: Serum cholesterol as a prog- nostic factor after myocardial infarction: the Framingham Study. Ann Intern Med 1991, 115:687- 693.

    Article  PubMed  CAS  Google Scholar 

  37. Scandinavian Simvastatin Survival Study Group: Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994, 344:1383–1389.

    Google Scholar 

  38. Lewis SJ, Sacks FM, Mitchell JS, et al., for the CARE Investigators: Effect of pravastatin on cardiovascular events in women after myocardial infarction: the Cholesterol and Recurrent Events (CARE) Trial. J Am Coll Cardiol 1998, 32:140–146.

    Article  PubMed  CAS  Google Scholar 

  39. Downs JR, Clearfield M, Weis S, et al., for the AFCAPS/TexCAPS Research Group: Primary prevention of acute coronary events withlovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. JAMA 1998, 279:1615–1622.

    Article  PubMed  CAS  Google Scholar 

  40. Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Study Group: Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Study Group. N Engl J Med 1998, 339:1349–1357.

    Article  Google Scholar 

  41. Clinical Trial Service Unit: HPS MRC/BHF Heart Protection Study. Accessible at http://www.hpsinfo.org

    Google Scholar 

  42. Barnard RJ: Effects of life-style modification on serum lipids. Arch Intern Med 1991, 151:1389–1394.

    Article  PubMed  CAS  Google Scholar 

  43. Anastos K, Charney P, Charon RA, et al.: Hypertension in women: what is really known? The Women’s Caucus, Working Group on Women’s Health of the Society of General Internal Medicine. Ann Intern Med 1991, 115:287–293.

    Article  PubMed  CAS  Google Scholar 

  44. National Center for Health Statistics: Health: United States, 1990. Hyattsville, MD: U.S. Public Health Service, Centers for Disease Control; 1991.

    Google Scholar 

  45. Hypertension Detection and Follow-up Program Cooperative Group: Persistence of reduction in blood pressure and mortality of participants in the Hypertension Detection and Follow-up Program. JAMA 1988, 259:2113–2122.

    Article  Google Scholar 

  46. Hypertension Detection and Follow-up Program Cooperative Group: Five-year findings of the Hypertension Detection and Follow-up Program. II: mortality by race-sex and age. JAMA 1979, 242:2572–2577.

    Article  Google Scholar 

  47. Medical Research Council Working Party: MRC trial of treatment of mild hypertension: principal results. BMJ 1985, 291:97–104.

    Article  Google Scholar 

  48. SHEP Cooperative Research Group: Prevention of stroke by antihy- pertensive drug treatment in older persons with isolated hyperten- sion. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991, 265:3255–3264.

    Article  Google Scholar 

  49. Barrett-Connor EL: Obesity, atherosclerosis and coronary artery disease. Ann Intern Med 1985, 103:1010–1019.

    Article  PubMed  CAS  Google Scholar 

  50. Spelsberg A, Ridker PM, Manson JE: Carbohydrate metabolism, obesity, and diabetes. In Cardiovascular Health and Disease in Women. Edited by Douglas PS. Philadelphia: WB Saunders Co.; 1993:191–216.

    Google Scholar 

  51. Hubert HB, Feinleib M, McNamara PM, et al.: Obesity as an inde- pendent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983, 67:968–977.

    Article  PubMed  CAS  Google Scholar 

  52. Willett WC, Manson JE, Stampfer MJ, et al.: Weight, weight change, and coronary heart disease in women: risk within the ‘normal’ weight range. JAMA 1995, 273:461–465.

    Article  PubMed  CAS  Google Scholar 

  53. Brownell KD, Stunkard AJ: Differential changes in plasma high- density lipoprotein-cholesterol levels in obese men and women during weight reduction. Arch Intern Med 1981, 141:1142–1146.

    Article  PubMed  CAS  Google Scholar 

  54. Soler JT, Folsom AR, Kushi LH, et al.: Association of body fat distri- bution with plasma lipids, lipoprotein, apolipoproteins AI and B in postmenopausal women. J Clin Epidemiol 1988, 41:1075–1081.

    Article  PubMed  CAS  Google Scholar 

  55. Larsson B, Bengtsson C, Bjorntorp P, et al.: Is abdominal body fat distribution a major explanation for the sex difference in the inci- dence of myocardial infarction? The Study of Men Born in 1913 and the Study of Women, Goteborg, Sweden. Am J Epidemiol 1992, 135:266–273.

    PubMed  CAS  Google Scholar 

  56. Kannel WB, Sorlie P: Some health benefits of physical activity. The Framingham Study. Arch Intern Med 1979, 139:857–861.

    Article  PubMed  CAS  Google Scholar 

  57. Blair SN, Kohl HW III, Paffenbarger RS Jr, et al.: Physical fitness and all-cause mortality. A prospective study of healthy men and women. JAMA 1989, 262:2395–2401.

    Article  PubMed  CAS  Google Scholar 

  58. Reaven PD, McPhillips JB, Barrett-Connor EL, et al.: Leisure time exercise and lipid and lipoprotein levels in an older population.J Am Geriatr Soc 1990, 38:847–854.

    PubMed  CAS  Google Scholar 

  59. Lokey EZ, Tran ZV: Effects of exercise training on serum lipid and lipoprotein concentrations in women: a meta-analysis. Int J Sports Med 1989, 10:424–429.

    Article  PubMed  CAS  Google Scholar 

  60. Hartung GH, Moore CE, Mitchell R, et al.: Relationship of menopausal status and exercise level to HDL cholesterol in women. Exp Aging Res 1984, 10:13–18.

    Article  Google Scholar 

  61. Manson JE, Rimm EB, Stampfer MJ, et al.: Physical activity and incidence of non-insulin dependent diabetes mellitus in women. lancet 1991, 338:774–778.

    Article  PubMed  CAS  Google Scholar 

  62. Ford ES, Giles WH, Dietz WH: Prevalence of the metabolicsyndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA 2002, 287:356–359.

    Article  PubMed  Google Scholar 

  63. Mann JI, Inman WHW: Oral contraceptives and death from myocardial infarction. BMJ 1975, 2:245–248.

    Article  PubMed  CAS  Google Scholar 

  64. Mann JI, Vessey MP, Thorogood M, et al: Myocardial infarction in young women with special reference to oral contraceptive prac- tice. BMJ 1975, 2:241–245.

    Article  PubMed  CAS  Google Scholar 

  65. Mann JI, Inman WHW, Thorogood M: Oral contraceptive use in older women and fatal myocardial infarction. BMJ 1976, 2:445–447.

    Article  PubMed  CAS  Google Scholar 

  66. Shapiro S, Slone D, Rosenberg L, et al.: Oral-contraceptive use in relation to myocardial infarction. Eancet 1979, 1:743–747.

    CAS  Google Scholar 

  67. Petitti DB, Wingerd J, Pellegrin F, et al.: Risk of vascular disease in women: smoking, oral contraceptives, noncontraceptive estro- gens, and other factors. JAMA 1979, 242:1150–1154.

    Article  PubMed  CAS  Google Scholar 

  68. Rosenberg L, Hennekens CH, Rosner B, et al.: Oral contraceptive use in relation to nonfatal myocardial infarction. Am J Epidemiol 1980, 111:59–66.

    PubMed  CAS  Google Scholar 

  69. Slone D, Shapiro S, Kaufman DW, et al.: Risk of myocardial infarc- tion in relation to current and discontinued use of oral contracep- tives. N Engl J Med 1981, 305:420–424.

    Article  PubMed  CAS  Google Scholar 

  70. Royal College of General Practitioners’ Oral Contraception Study: Further analyses of mortality in oral contraceptive users. Eancet 1981, 1:541–546.

    Google Scholar 

  71. Stampfer MJ, Willett WC, Colditz GA, et al.: A prospective study of past use of oral contraceptive agents and risk of cardiovascular disease. N Engl J Med 1988, 319:1313–1317.

    Article  PubMed  CAS  Google Scholar 

  72. Stampfer MJ, Willett WC, Colditz GA, et al.: Past use of oral contraceptives and cardiovascular disease: a meta-analysis in the context of the Nurses’ Health Study. Am J Obstet Gynecol 1990, 163:285–291.

    Article  PubMed  CAS  Google Scholar 

  73. Barrett-Connor E, Bush TL: Estrogen and coronary heart disease in women. JAMA 1991, 265:1861–1867.

    Article  PubMed  CAS  Google Scholar 

  74. Palmer JR, Rosenberg L, Shapiro S: Reproductive factors and risk of myocardial infarction. Am J Epidemiol 1992, 136:408–416.

    PubMed  CAS  Google Scholar 

  75. Knopp RH: The effects of postmenopausal estrogen therapy on the incidence’of arteriosclerotic vascular disease. Obstet Gynecol 1988, 72(suppl 5):23s-30s.

    PubMed  CAS  Google Scholar 

  76. Walsh BW, Schiff I, Rosner B, et al.: Effects of postmenopausal estrogen replacement on the concentration and metabolism of plasma lipoproteins. N Engl J Med 1991, 325:1196–1204.

    Article  PubMed  CAS  Google Scholar 

  77. Barrett-Connor E, Laakso M: Ischemic heart disease risk in post- menopausal women. Effects of estrogen use on glucose and insulin levels. Arteriosclerosis 1990, 10:531–534.

    Article  PubMed  CAS  Google Scholar 

  78. The Writing Group for the PEPI Trial: Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in post- menopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA 1995, 273:199–208.

    Article  Google Scholar 

  79. Cushman M, Legault C, Barrett-Connor E, et al.: Effect of post- menopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen Progestin Interventions (PEPI) Study. Circulation 1999, 100:717–722.

    Article  PubMed  CAS  Google Scholar 

  80. Lafferty FW, Helmuth DO: Post-mendpausal estrogen replacement: the prevention of osteoporsis and systemic effects. Maturitas 1985, 7: 47–59.

    Article  Google Scholar 

  81. Stampfer MJ, Willet WC, Colditz GA, et al.: A prospective study of postmenopausal estrogen therapy and coronary heart disease. N Engl J Med 1985, 313:1044–1049.

    Article  PubMed  CAS  Google Scholar 

  82. Nachtigall LE, Nachtigall RH, Nachtigall RD, et al.: Estrogen replacement therapy, II: a prospective study in the relationship to carcinoma and cardiovascular and metabolic problems. Obstet Gynecol 1979, 54:74–79

    Article  PubMed  CAS  Google Scholar 

  83. Hammond CB, Jelovsek FR, Lee KL, et al.: Effects of long-term estrogen replacement therapy. I: metabolic effects. Am J Obstet Gynecol 1979, 133:525–536.

    PubMed  CAS  Google Scholar 

  84. Bush TL, Barrett-Connor E, Cowan LD, et al.: Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study Circulation 1987, 75:1102–1109.

    Article  PubMed  CAS  Google Scholar 

  85. Talbott E, Kuller LH, Detre K, et al.: Biologic and psychosocial risk factors of sudden death from coronary disease in white women. Am J Cardiol 1977, 39:858–864.

    Article  PubMed  CAS  Google Scholar 

  86. Rosenberg L, Armstrong B, Jick H, et al.: Myocardial infarction and estrogen therapy in postmenopausal women. N Engl J Med 1976, 294:1256–1259.

    Article  PubMed  CAS  Google Scholar 

  87. Henderson BE, Paganini-Hill A, Ross RK: Estrogen replacement therapy and protection from acute myocardial infarction. Am J Obstet Gynecol 1988, 159:312–317.

    PubMed  CAS  Google Scholar 

  88. Beard CM, Kottke TE, Annegers JF, et al.: The Rochester Coronary Heart Disease Project: effect of cigarette smoking, hypertension, diabetes, and steroidal estrogen use on coronary heart disease among 40- to 59-year old women, 1969 through 1982. Mayo Clin Proc 1989, 64:1471–1480.

    Article  PubMed  CAS  Google Scholar 

  89. Petitti DB, Perlman JA, Sidney S: Noncontraceptive estrogens and mortality: long-term followup of women in the Walnut Creek study. Obstet Gynecol 1987, 70:289–293.

    PubMed  CAS  Google Scholar 

  90. Avila MH, Walker AM, Jick H: Use of replacement estrogens and the risk of myocardial infarction. Epidemiology 1990, 1:128–135.

    Article  Google Scholar 

  91. Adam S, Williams V, Vessey MP: Cardiovascular disease and hormone replacement treatment: a pilot case-control study. BMJ 1981, 282:1277–1278.

    Article  PubMed  CAS  Google Scholar 

  92. Szklo M, Tonascia J, Gordis L, et al.: Estrogen use and myocardial infarction risk: a case-control study. Prev Med 1984, 13:510–516.

    Article  PubMed  CAS  Google Scholar 

  93. Rosenberg L, Slone D, Shapiro S, et al.: Noncontraceptive estrogens and myocardial infarction in young women. JAMA 1980, 244:339–342.

    Article  PubMed  CAS  Google Scholar 

  94. Thompson SG, Meade TW, Greenberg G: The use of hormonal replacement therapy and the risk of stroke and myocardial infarc- tion in women. J Epidemiol Commun Health 1989, 43:173–178

    Article  CAS  Google Scholar 

  95. LaVecchia C, Franceschi S, Decarli AS, et al.: Risk factors for myocardial infarction in young women. Am J Epidemiol 1987, 125:832–843.

    CAS  Google Scholar 

  96. Wilson PWF, Garrison RJ, Castelli WP: Postmenopausal estrogen use and heart disease. N Engl J Med 1986, 315:135.

    Google Scholar 

  97. Jick H, Dinan B, Rothman KJ: Noncontraceptive estrogens and nonfatal myocardial infarction. JAMA 1978, 239:1407–1409.

    Article  PubMed  CAS  Google Scholar 

  98. Stampfer MJ, Colditz GA, Willett WC, et al: Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the Nurses’ Health Study. N Engl J Med 1991, 325:756–762.

    Article  PubMed  CAS  Google Scholar 

  99. Sullivan JM, Vander Zwaag R, Hughes JP, et al.: Estrogen replace- ment and coronary artery disease. Effect on survival in post- menopausal women. Arch Intern Med 1990, 150:2557–2562.

    Article  PubMed  CAS  Google Scholar 

  100. Herrington DM, Reboussin DM, Brosnihan KB, et al.: Effects of estrogen replacement on the progression of coronary-artery ather- osclerosis. N Engl J Med 2000, 343:522–529.

    Article  PubMed  CAS  Google Scholar 

  101. Henderson BE, Paganini-Hill A, Ross RK: Decreased mortality in users of estrogen replacement therapy. Arch Intern Med 1991, 151:75–78.

    Article  PubMed  CAS  Google Scholar 

  102. Falkeborn M, Persson I, Adami H-O, et al.: The risk of acute myocardial infarction after oestrogen and oestrogen-progestogen replacement. Br J Obstet Gynecol 1992, 99:821–828.

    Article  CAS  Google Scholar 

  103. Hulley S, Grady D, Bush T, et al., for the Heart and Estrogen/prog- estin Replacement Study (HERS) Research Group: Randomized trial of estrogen plus progestin for secondary prevention of coro- nary heart disease in postmenopausal women. JAMA 1998, 280:605–613.

    Article  PubMed  CAS  Google Scholar 

  104. Grady D, Wenger NK, Herrington D, et al., for the Heart and Estrogen/progestin Replacement Study Research Group: Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/progestin Replacement Study. Ann Intern Med 2000, 132:689–696.

    Article  PubMed  CAS  Google Scholar 

  105. Viscoli CM, Brass LM, Kernan WN, et al.: A clinical trial of estrogen-replacement therapy after ischemic stroke. N Engl J Med 2001, 345:1243–1249.

    Article  PubMed  CAS  Google Scholar 

  106. Walsh BW, Kuller LH, Wild RA, et al.: Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women. JAMA 1998, 279:1445–1451.

    Article  PubMed  CAS  Google Scholar 

  107. Barrett-Connor E, Wenger NK, Grady D, et al.: Hormone and nonhormone therapy for the maintenance of postmenopausal health: the need for randomized controlled trials of estrogen and raloxifene. J Women’s Health 1998, 7:839–847.

    Article  CAS  Google Scholar 

  108. Barrett-Connor E, Grady D, Sashegyi A, et al.: Raloxifene and cardiovascular events in osteoporotic postmenopausal women: four-year results from the MORE (Multiple Outcomes of Raloxifene Evaluation) randomized trial. JAMA 2002, 287:847–857.

    Article  PubMed  CAS  Google Scholar 

  109. Manson JE, Stampfer MJ, Colditz GA, et al.: A prospective study of aspirin use and primary prevention of cardiovascular disease in women. JAMA 1991, 266:521–527.

    Article  PubMed  CAS  Google Scholar 

  110. American Diabetes Association: Aspirin therapy in diabetes. Diabetes Care 2001, 24 (suppl 10):S62-S63.

    Google Scholar 

  111. US Preventive Services Task Force: Aspirin for the primary prevention of cardiovascular events: recommendation and ratio- nale. Ann Intern Med 2002, 136:157–160.

    Article  Google Scholar 

  112. Hayden M, Pignone M, Phillips C, et al.: Aspirin for the primary prevention of cardiovascular events: a summary of the evidence for the US Preventive Services Task Force. Ann Intern Med 2002, 136:161–172.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Nanette K. Wenger
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Boston University School of Medicine, Boston, Massachusetts, USA

    Peter W. F. Wilson MD (Professor of Medicine, Director of Laboratories) (Professor of Medicine, Director of Laboratories)

  2. Framingham Heart Study, Framingham, Massachusetts, USA

    Peter W. F. Wilson MD (Professor of Medicine, Director of Laboratories) (Professor of Medicine, Director of Laboratories)

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer Science+Business Media New York

About this chapter

Cite this chapter

Wenger, N.K. (2003). Gender Differences in Coronary Risk Factors and Risk Interventions. In: Wilson, P.W.F. (eds) Atlas of Atherosclerosis. Current Medicine Group, London. https://doi.org/10.1007/978-1-4615-6484-3_12

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-6484-3_12

  • Publisher Name: Current Medicine Group, London

  • Print ISBN: 978-1-4615-6486-7

  • Online ISBN: 978-1-4615-6484-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation